Related Experiment Video

Updated: May 22, 2026

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand

Carmela Parenti1, Rita Turnaturi, Giuseppina Aricò

  • 1Department of Drug Sciences, Pharmacology and Toxicology section, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.

Life Sciences
|May 15, 2012
PubMed
Abstract

Insights

LP1, a mixed mu-opioid receptor (MOR) and delta-opioid receptor (DOR) ligand, provides supraspinal pain relief. This multitarget opioid agent offers a promising new avenue for chronic pain management.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Management

Background:

  • Opioid receptors, including mu-opioid receptor (MOR) and delta-opioid receptor (DOR), are key targets for pain relief.
  • Multitarget ligands offer potential for enhanced efficacy and reduced side effects in pain management.
  • Previous research identified LP1 as a MOR-DOR ligand with prolonged antinociception compared to morphine.

Purpose of the Study:

  • To determine if the antinociceptive effects of LP1 are central or peripheral.
  • To identify the specific opioid receptor subtypes involved in LP1's antinociceptive action.

Main Methods:

  • Investigated LP1's antinociception using intracerebroventricular and subcutaneous administration of naloxone methiodide (NX-M), a quaternary opioid antagonist.
  • Administered selective antagonists for MOR, DOR, and kappa-opioid receptor (KOR) to assess LP1's receptor involvement.
  • Examined LP1's effects on DPDPE, a selective DOR agonist, to better characterize its DOR profile.

Main Results:

  • LP1 demonstrated predominantly MOR-mediated supraspinal antinociception, as evidenced by tail flick test data.
  • LP1 was effective in counteracting the analgesic effects of DPDPE, a selective DOR agonist.

Conclusions:

  • LP1 acts as a supraspinal analgesic agent.
  • LP1's multitarget activity, primarily through MOR, makes it a valuable therapeutic candidate for chronic pain.
  • The findings support LP1's potential for treating chronic pain conditions.

More Related Videos

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...